Estrima SpA
MIL:BIRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
|
Seven & i Holdings Co Ltd
F:S6M
|
JP |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
H
|
Halliburton Co
XHAM:HAL
|
US |
|
D
|
Deutsche Boerse AG
XHAM:DB1
|
DE |
|
Mizuho Financial Group Inc
F:MZ8
|
JP |
|
Arcosa Inc
NYSE:ACA
|
US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
E
|
Erlebnis Akademie AG
DUS:EAD
|
DE |
|
A
|
Anglo American PLC
XMUN:NGLB
|
UK |
Wall St Price Targets
BIRO Price Targets Summary
Estrima SpA
According to Wall Street analysts, the average 1-year price target for BIRO is 0.153 EUR with a low forecast of 0.1515 EUR and a high forecast of 0.1575 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIRO's stock price target?
Price Target
0.153
EUR
According to Wall Street analysts, the average 1-year price target for BIRO is 0.153 EUR with a low forecast of 0.1515 EUR and a high forecast of 0.1575 EUR.
What is the Revenue forecast for Estrima SpA?
Projected CAGR
7%
Over the last 4 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 6 years is 7%.
What is the Gross Profit forecast for Estrima SpA?
Projected CAGR
-13%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 2 years is -13%.